| Site |
Sponsor |
Study Title |
| Breast |
| B-43 |
NSABP |
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy |
| CREP |
UPCC |
Familial Breast Cancer Studies |
| 3108 |
ECOG |
A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen |
| 2108 |
ECOG |
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
|
| MA-32 |
NCIC CTG |
Phase III Randomized Trial of the Effect of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer |
| 1007 |
SWOG |
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less (RxPONDER: Rx for Positive Node, Endocrine Responsive Breast Cancer) |
| 80702 |
WFU |
Impact of Genomics and exposures on disparities in breast cancer radiosensitivity |
| GI |
| 80702 |
CALGB |
A Phase III Trial of 6 versus 12 treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer. |
| GU |
| 0534 |
RTOG |
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy |
| 0931 |
SWOG |
EVEREST: Everolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study |
| GYN |
| 0249 |
GOG |
A Phase III Trial of Pelvic Radiation Therapy versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk Early Stage Endometrial Carcinoma |
| HEME |
| Simplicity |
Bristol -Myers |
Studying Interventions for Managing Patients with Chronic Myeloid Leukemia in Chronic Phase: The 5-Year Prospective Cohort Study |
| Lung |
|
5508
|
ECOG |
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC. |
|
6508
|
ECOG |
A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non Squamous Non Small Cell Lung Cancer After Definitive Chemoradiation |
|
G300504
|
GTx, Inc. |
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients with Non-Small Cell Lung Cancer on First Line Platinum Plus a Taxane Chemotherapy |
|
G300505
|
GTx, Inc. |
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients with Non-Small Cell Lung Cancer on First Line Platinum Plus a Non-Taxane Chemotherapy
|